Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Erbitux submitted to E.U. and Swiss regulatory authorities

July 8, 2003

New EGFR/HER2 kinase inhibitors under study at Wyeth

July 8, 2003

Approval sought for Plenaxis in Germany

July 7, 2003

Phase I trial initiated for MLN-944

July 7, 2003

SAHA enters phase I trial in advanced leukemias

July 7, 2003

New Src/MEK kinase inhibitors in early development at AstraZeneca

July 7, 2003

Endovion shows promising results in preclinical and phase I studies

July 4, 2003

Trials confirm the efficacy and safety of bortezomib in multiple myeloma and mantle cell lymphoma

July 4, 2003

Genmab files CTA to begin phase I/II trial of HuMax-EGFr

July 4, 2003

Genasense receives fast track designation in CLL

July 4, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026